Dipexium Pharmaceuticals’ Lock-Up Period Set To Expire on September 9th (NASDAQ:DPRX)
Dipexium Pharmaceuticals’ (NASDAQ:DPRX) lock-up period will end on Tuesday, September 9th. Dipexium Pharmaceuticals had issued 2,750,000 shares in its public offering on March 13th, AR Network reports. The total size of the offering was $33,000,000 based on an initial share price of $12.00. After the end of Dipexium Pharmaceuticals’ lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.
Dipexium Pharmaceuticals (NASDAQ:DPRX) remained flat at $9.60 during during mid-day trading trading on Thursday. Dipexium Pharmaceuticals has a one year low of $8.00 and a one year high of $15.86. The stock has a 50-day moving average of $9.38 and a 200-day moving average of $9.76. The company’s market cap is $82.0 million.
Dipexium Pharmaceuticals (NASDAQ:DPRX) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.46) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.37) by $0.09. Analysts expect that Dipexium Pharmaceuticals will post $-1.94 EPS for the current fiscal year.
Dipexium Pharmaceuticals, Inc, formerly Dipexium Pharmaceuticals, LLC, is a pharmaceutical company. The Company is focused on the development and commercialization of Locilex.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.